New prognostic model for predicting outcomes in patients with acute-on-chronic liver failure

Early determination of prognosis in patients with acute-on-chronic liver failure (ACLF) is crucial for optimizing treatment options and liver allocation. This study aimed to identify risk factors associated with ACLF and to develop new prognostic models that accurately predict patient outcomes.

J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson has linked

November 6, 2023

Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) – Biotech Investments

Lonza Group AG / Key word(s): Partnership Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) 24.09.2024 / 14:00 CET/CEST Lonza

September 25, 2024

Vorasidenib for Low-Grade Glioma Doubles Progression-Free Survival

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a global phase III trial showing that the targeted therapy vorasidenib more

July 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.